精选行业洞察美国 FDAT1072
FDA Approves First Single-Dose Generic Treatment for Influenza
🤖 AI 摘要
The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.
分析模型：rule-based-v3 · 07-09 06:59
评分详情
综合分 72/100
信源权威
95
影响范围
75
时效性
50
合规紧急
40
行业关注
75
FDA Press Releases (新闻发布)
操作：